No Data
No Data
A Quick Look at Today's Ratings for LENZ Therapeutics(LENZ.US), With a Forecast Between $38 to $60
LENZ Therapeutics Price Target Raised to $47.00/Share From $44.00 by Citigroup
LENZ Therapeutics Is Maintained at Buy by Citigroup
LENZ Therapeutics Analyst Ratings
Express News | Lenz Therapeutics Inc : Citigroup Raises Target Price to $47 From $44
Earnings Call Summary | LENZ Therapeutics(LENZ.US) Q4 2024 Earnings Conference